How Timely Expert-Led Education Accelerates Clinical Decision-Making
Ken Ruppel
In precision medicine, clinical decision-making is becoming more complex, time‑sensitive, and data-dependent. And that data is often difficult to interpret in isolation. Biomarker reports, evolving guideline updates, new therapy indications. All with rapidly shifting evidence, converging when physicians need clarity, not volume.
Yet across the industry, a familiar pattern persists: the right information is available. Just not at the moment when a physician is actually making a therapeutic choice.
As Sarah Kurz, President and COO at Partner Therapeutics, explains:
“Physicians want to be educated at the right time. They aren’t seeing these patients frequently enough to want to spend the mental energy until they have that patient in front of them."
This reveals a key truth: clinicians aren’t disengaged. They’re overwhelmed by competing demands and constrained by the need to focus only on what’s immediately actionable. Precision medicine multiplies that tension.
The point of clinical decision-making is where momentum is made or lost
The biggest barrier to therapy conversion is not unwillingness. It’s timing. Information that arrives outside the clinical decision-making window rarely shapes what happens next.
Peter Finlayson, VP of Marketing at Partner Therapeutics, highlights:
“It’s not because physicians don’t want patients to have those medications. It’s just that the information isn’t making it into the physician’s hands at that time.”
This challenge is not solved by more awareness campaigns or more digital content. In fact, as Kurtz noted:
“You cannot solve everything with digital content alone.”
Digital channels play a role. However, these decisions are often nuanced, uncertain, or dependent on clinical interpretation. Physicians often need something more grounded. A conversation with another expert.
Why peer‑to‑peer dialogue cuts through where traditional outreach doesn’t
Therapeutic decisions, especially those tied to biomarker‑driven care, aren’t just about data. They’re about confidence. Physicians need the space to ask questions, test assumptions, and understand how peers would navigate similar scenarios.
This is why relationships remain central to clinical momentum. These conversations aren’t promotional; they’re interpretive. They translate evidence into real‑world application and help physicians move forward with clarity under pressure.
The challenge is not persuading clinicians. It’s providing the right expert, at the right level, at the right moment.
Beyond individual clinicians: momentum depends on the whole care team
Another overlooked barrier to therapy conversion is fragmentation across the wider care ecosystem. Pathologists, oncologists, specialist nurses, and diagnostic teams often operate with different timelines, pressures, and insights.
Supporting only one stakeholder rarely resolves delays. The entire care pathway influences whether therapy decisions happen with confidence. Targeting the whole care team is critical to improving consistency and momentum.
The missing link: a way to activate timely, senior‑level, peer‑to‑peer education
The industry has long acknowledged the importance of clinical conversation. But operationalising it in a compliant, relevant, and timely way has remained difficult. Traditional outreach is too slow, too broad, or too detached from real clinical triggers.
What’s needed is an approach that delivers peer dialogue quickly and credibly. Furthermore, it needs to be within the therapeutic decision window. Not weeks or months later.
Ken Ruppel VP of Scientific & Medical Services discusses how to bridge the gap between insight and action, so no eligible patient is left behind.
Diaceutics Expert Exchange has become a trusted engagement engine
Expert Exchange is a proven model for sparking timely, senior-level, peer-to-peer clinical dialogue. And, doing so precisely when clinical decision-making happens. By activating engagements within the critical diagnostic-to-treatment window, meaningful conversations can be driven. And it's those conversations that can build confidence, reduce uncertainty, and naturally support smoother therapy conversion across the entire care team.
What Expert Exchange delivers:
-
Timely activation at the point of decision: Initiates expert-led discussions in as little as 48 hours. This is during the exact moment when diagnostic results are being interpreted and treatment plans are being formed.
-
Whole-care-team engagement: Connects the full ecosystem of clinicians involved in the patient journey. Reduce fragmentation while aligning clinical decision-making teams in that process.
-
Contextual, case-based conversation: Engagements are triggered by real patient scenarios. This enables clinicians to explore questions that don’t fit into promotional materials.
-
Measured, reliable impact: 90% success rate in contacting target HCP institutions. 75% HCP engagement rate post-implementation.
“Being able to engage them at the right time in the right place allows us to make a real difference for patients.” — Kurtz
Expert Exchange: building clinical decision-making confidence that drives action
Expert Exchange connects diagnostic experts with treating physicians to drive confident prescribing through peer-to-peer education. This helps give your brand a trusted clinical voice to clearly explain testing. That is, a therapeutic link in a credible, non- promotional format.
What is peer-to-peer physician education in precision medicine?
Why do physicians ignore medical education content until they have a relevant patient?
How quickly should HCP education happen after a biomarker test result?
Why does physician engagement stall even when a therapy is clinically appropriate?
Who else besides the prescribing physician influences a precision medicine treatment decision?
What's the difference between digital HCP outreach and expert-led peer conversation?
Written By Ken Ruppel
Newsletter sign up
READY TO DO COMMERCIALIZATION DIFFERENTLY?
You might also be interested in?
Amplifying Your Precision Medicine Strategy: The role of Engagement Experts and Peer Networks
Enhance your precision medicine strategy through multi-modal communications and peer engagement, driving effective diagnostic commercialization and maximizing patient outcomes.
Redefining HCP Engagement with Clinical, Behavioral & Companion Diagnostics
Transform HCP engagement by integrating clinical, behavioral, and companion diagnostics data for precise targeting and improved outreach effectiveness. Discover the future of pharma marketing.